We are CLBiomed

Cheerland Biomedicine (CLBiomed) aims to build a world-class science and technology enterprise, offering millions of people a wide array of products and services, ranging from molecular diagnostics, innovative therapeutics, and healthcare services. We are rapidly expanding our pipelines and products through venture investment, co-development deals, and in-house R&D. We are Cheerland, the Land of Curing and Caring.

: Molecular Diagnostics »

Led by molecular diagnostic technology, we integrate R&D, production, sales and clinical testing services of testing reagents to provide the highest quality molecular diagnostic testing services for Chinese cancer and reproductive patients, as well as people who are interested in their “book of life” and genetics-based preventative medicine and/or health management.

:: Innovative Therapeutics »

We develop small molecules and bioliogics for major diseases such as tumors, cardiovascular diseases and infectious diseases, through a multi-pronged approach: Independent research and development + project introduction and integration + investment mergers and acquisitions.

::: Healthcare Services »

We are building an ecosystem of healthcare solutions and services, in our elder-care, rehabilitation projects in several strategically located sites near Beijing, Shanghai and Shenzhen. We provide a full range of medical services covering prevention, diagnosis, treatment, rehabilitation, medical care, which include precision testing, disease prevention, chronic disease management, drug therapy, stem cell therapy, and other advanced services.


MDx products


satisfied customers


investment and co-development projects

💖 Any questions regarding project investment and financing, products and services, marketing cooperation, R&D collaborations with scientific research institutions…we’d love to hear from you!

CLBiomed Team

Nobel Prize winner, academician of the American Academy of Sciences. One of the most famous scientists of the twentieth century. He co-discovered the DNA double helix structure in 1953 and won the Nobel Prize in Physiology or Medicine in 1962. He is known as “Einstein of Life Sciences” and “Father of DNA” …»

Extensive experiences in capital investment and business operations in China and abroad. He has established several successful companies in various industries at home and abroad, and has successfully led many cross-border and cross-market transformations of the companies he founded.

Renowned financier and entrepreneur, Dr. Ma is currently the chairman of the board of directors of the Shenzhen International Public Welfare Institute, the executive director of the Chinese Finance Society, and the executive director of the Chinese Business Leaders’ Association. Former director and president of China Merchants Bank; Chairman of the National Science and Technology Achievement Transformation Guidance Fund, among other key positions.

Dr. Su has 30 years’ experiences in biotech and pharmaceutical industry in US/Europe/Asia in biological product development including Research and Development, Process Sciences, Manufacturing, Analytical Sciences, Quality System and Regulatory Affairs. He has involved with multiple IND and BLA submissions in the US/China, as well as building several cGMP facilities in US and China. He has served at the executive positions in biotech start-ups as well as multi-national pharma companies …»


Every year, I would purchase a physical examination package for my parents. Last year, under the recommendation of a friend, I gave my parents a “tumor susceptibility gene test (advanced package)”. The test report suggested that my father had higher risks for esophageal cancer, prostate cancer, and kidney cancer. My mother has a higher risk of breast cancer and stomach cancer. In response to the test results, my parents have paid more attention to the physical examination in the past two years. At the beginning of this year, my mother found some early cancer tissue in her mammary gland. The doctor said it was relatively early and she was cured by surgical removal of those cells. Thanks to Cheerland’s tumor susceptibility gene test to let my family members understand their own risk of disease, and achieve early detection and early treatment of cancer.

My baby had a fever when he was 3 years old, and the hospital prescribed ibuprofen. After taking it, the fever is down but there was blood in the stool. He was sent to the hospital immediately. The doctor suspected that it may be related to ibuprofen. Cheerland’s “Children’s Drug Metabolic Gene Test” found that the baby’s metabolic capacity for ibuprofen is low, and the normal dose has a large side effect on gastrointestinal toxicity. It is recommended to reduce the dosage of ibuprofen or switch to other analgesic medicine. I always keep this in mind for the baby’s medication.

I have suffered from high blood pressure for many years. I have adjusted my medication plan many times, and it has been increased to a four-drug combination of “amlodipine + valsartan + metoprolol + captopril”. However the effect is still not good. I did a “Hypertension Drug Gene Testing” in Cheerland, which indicated that the use of amlodipine, valsartan, and captopril is not effective. According to the test results, the medication regimen was adjusted to “Nitrendipine + Telmisartan + Metoprolol + Benazepril”. After taking it for a period of time, my blood pressure decreased and was under control.

Seeing that I have gout, the genetic counsellor at Cheerland reminded me that taking diuretic hypertension drugs increases the risk of uric acid and should avoid using these drugs. Thanks for the great service and insights, Cheerland!